Effect of HCG on pregnancy

Phase 2

• Conditions: Diseases of the genitourinary system.; Noninflammatory disorders of female genital tract; N00-N99

• Registration Number: IRCT2014122320408N1
• Lead Sponsor: Infertility & Reproductive Health Research Center of Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 308

Inclusion Criteria

Women aged 20-40 years undergoing fresh intracytoplasmic sperm injection -embryo transfer cycles that have normal endometrial thickness (7-12 milimeters) on the day of embryo transfer and thay dont have any visible endometrial pathology, And they have less than three failed previous intracytoplasmic sperm injection cycles, BMI <30, And duration of infertility less than 10 years are included.
Exclusion criteria: Abnormally shaped uterus in hysterosalpingography or hysteroscopy, More than 3 previous failure of intracytoplasmic sperm injection-embryo transfer cycles, BMI> 30, And duration of infertility is more than 10 years and severe male infertility.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical pregnancy rate. Timepoint: Five weeks after start of intervention. Method of measurement: Transvaginal ultrasonography.;Implantation rate. Timepoint: End of the treatment. Method of measurement: Statistical analysis.

Secondary Outcome Measures

Name	Time	Method
Chemical pregnancy rate. Timepoint: Two weeks after embryo transfer. Method of measurement: Labratory kit.;Miscariage rate. Timepoint: Until 24 weeks after start of intervention. Method of measurement: History, physical exam, ultrasonography.;Fertilization rate. Timepoint: After embryo development. Method of measurement: Labratory investigation.